Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma
Tags: APLASTIC anemia; CYCLOSPORINE; HEMATOPOIETIC stem cells -- Transplantation
Related Articles
- Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor. Aljurf, M; Al-Zahrani, H; Van Lint, M T; Passweg, J R // Bone Marrow Transplantation;Feb2013, Vol. 48 Issue 2, p178
Matched related donor allo-SCT is the treatment of choice for patients with severe aplastic anemia (SAA) younger than 40 years of age. The standard conditioning regimen for such patients is cyclophosphamide with antithymocyte globulin. Unmanipulated BM is the best stem cell source for aplastic...
- Rabbit-antithymocyte globulin combined with cyclosporin A as a first-line therapy: improved, effective, and safe for children with acquired severe aplastic anemia. Chen, Chun; Xue, Hong-Man; Xu, Hong-Gui; Li, Yang; Huang, Ke; Zhou, Dun-Hua; Guo, Hai-Xia; Fang, Jian-Pei; Huang, Shao-Liang // Journal of Cancer Research & Clinical Oncology;Jul2012, Vol. 138 Issue 7, p1105
Purpose: Acquired aplastic anemia is an organ-specific auto-immune disease characterized by pancytopenia and hypoplastic bone marrow. Immunosuppression with anti-thymocyte globulin (ATG) and cyclosporine A (CsA) is an effective and safe therapy for patients without undergoing hematopoietic stem...
- Antibodies to anti-thymocyte globulin in aplastic anemia patients have a negative impact on hematopoietic SCT. Jol-van der Zijde, C M; Bredius, R G M; Jansen-Hoogendijk, A M; Smiers, F J; Lankester, A C; van Tol, M J D // Bone Marrow Transplantation;Sep2012, Vol. 47 Issue 9, p1256
A letter to the editor is presented which discusses a pediatric severe aplastic anemia (SAA) transplant cohort study which evaluates the efficacy of anti-thymocyte globulin (ATG) as first-line therapy in the hematopoietic stem cell transplantation (HSCT) conditioning regimen.
- Aplastic Anemia: Which Treatment? Abkowitz, Janis L. // Annals of Internal Medicine;10/2/2001, Vol. 135 Issue 7, p524
Editorial. Focuses on the proposed options for the treatment of aplastic anemia. Significance of the interventions of allogeneic hematopoietic stem-cell transplantation and immunosuppression; Considerations on short-term toxicity, rapidity, hematologic recovery and late complications; Purpose...
- First-Line Matched Related Donor Hematopoietic Stem Cell Transplantation Compared to Immunosuppressive Therapy in Acquired Severe Aplastic Anemia. Peinemann, Frank; Grouven, Ulrich; Kröger, Nicolaus; Bartel, Carmen; Pittler, Max H.; Lange, Stefan // PLoS ONE;2011, Vol. 6 Issue 4, p1
Introduction: Acquired severe aplastic anemia (SAA) is a rare and progressive disease characterized by an immunemediated functional impairment of hematopoietic stem cells. Transplantation of these cells is a first-line treatment option if HLA-matched related donors are available. First-line...
- Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Strahm, B.; N�llke, P.; Zecca, M.; Korthof, E. T.; Bierings, M.; Furlan, I.; Sedlacek, P.; Chybicka, A.; Schmugge, M.; Bordon, V.; Peters, C.; O'Marcaigh, A.; de Heredia, C. D.; Bergstraesser, E.; Moerloose, B. D.; van den Heuvel-Eibrink, M. M.; Star�, J.; Trebo, M.; Wojcik, D.; Niemeyer, C. M. // Leukemia (08876924);Mar2011, Vol. 25 Issue 3, p455
We report on the outcome of children with advanced primary myelodysplastic syndrome (MDS) transplanted from an HLA-matched sibling (MSD) or an unrelated donor (UD) following a preparative regimen with busulfan, cyclophosphamide and melphalan. Ninety-seven patients with refractory anemia with...
- Syngeneic peripheral blood stem cell transplantation with immunosuppression for hepatitis-associated severe aplastic anemia. Savic, Aleksandar; Balint, Bela; Urosevic, Ivana; Rajic, Nebojsa; Todorovic, Milena; Percic, Ivanka; Popovic, Stevan // Turkish Journal of Hematology;Dec2010, Vol. 27 Issue 4, p294
Hepatitis-associated aplastic anemia occurs in up to 10% of all aplastic anemia cases. Syngeneic bone marrow transplantation is rare in patients with severe aplastic anemia and usually requires pre-transplant conditioning to provide engraftment. We report on a 29-year-old male patient with...
- Rhizomucor and Scedosporium Infection Post Hematopoietic Stem-Cell Transplant. Marques, Dânia Sofia; Vaz, Carlos Pinho; Branca, Rosa; Campilho, Fernando; Lamelas, Catarina; Afonso, Luis Pedro; Jacome, Manuel; Breda, Eduardo; Monteiro, Eurico; Júnior, António Campos // Case Reports in Medicine;2011, p1
Hematopoietic stem-cell transplant recipients are at increased risk of developing invasive fungal infections. This is a major cause of morbidity and mortality. We report a case of a 17-year-old male patient diagnosed with severe idiopathic acquired aplastic anemia who developed fungal...
- A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome. Kim, Hawk; Lee, Je-Hwan; Joo, Young-Don; Bae, Sung; Hyun, Myung; Lee, Jung-Hee; Kim, Dae-Young; Lee, Won-Sik; Ryoo, Hun; Kim, Min; Park, Jae-Hoo; Lee, Kyoo-Hyung // Annals of Hematology;Sep2012, Vol. 91 Issue 9, p1459
Recently, a less toxic regimen comprising reduced cyclophosphamide (Cy), fludarabine, and anti-thymocyte globulin (ATG) (Cy-Flu-ATG) was used to condition high-risk patients scheduled for allogeneic hematopoietic cell transplantation (alloHSCT) instead of standard Cy-ATG in patients with severe...
